Periprosthetic infection due to resistant staphylococci: serious problems on the horizon. Academic Article uri icon

Overview

abstract

  • UNLABELLED: Prosthetic joint infections (PJI) caused by methicillin-resistant staphylococci represent a major therapeutic challenge. We examined the effectiveness of surgical treatment in treating infection of total hip or knee arthroplasty caused by methicillin-resistant staphylococcal strains and the variables influencing treatment success. One hundred and twenty-seven patients were treated at our institution between 1999 and 2006. There were 58 men and 69 women, with an average age of 66 years. Patients were followed for a minimum of 2 years or until recurrence of infection. Débridement and retention of the prosthesis was performed in 35 patients and resection arthroplasty in 92. Débridement controlled the infection in only 37% of cases whereas two-stage exchange arthroplasty controlled the infection in 75% of hips and 60% of knees. Preexisting cardiac disease was associated with a higher likelihood of failure to control infection in all treatment groups. Antibiotic-resistant Staphylococci continue to compromise treatment outcome of prosthetic joint infections, especially in patients with medical comorbidities. New preventive and therapeutic strategies are needed. LEVEL OF EVIDENCE: Level IV, therapeutic study.

publication date

  • May 1, 2009

Research

keywords

  • Methicillin-Resistant Staphylococcus aureus
  • Prosthesis-Related Infections
  • Staphylococcal Infections

Identity

PubMed Central ID

  • PMC2690767

Scopus Document Identifier

  • 67649798542

Digital Object Identifier (DOI)

  • 10.1007/s11999-009-0857-z

PubMed ID

  • 19408061

Additional Document Info

volume

  • 467

issue

  • 7